MDIF 2012 - Beyond M&A: Medical Device Exits
The panel details how the markets are changing for corporate mergers and acquisitions as traditional IPOs have largely evaporated and larger companies seek a return to effective product development. Identifying, attracting, and negotiating a strategic acquisition - as well as what to expect before, during and after - is discussed.
The discussion "Beyond M&A: Medical Device Exits" is led by a panel of speakers including:
David Allen and Michael Hedge, both partners at K&L Gates;
Raymond Cohen, CEO of Vessix Vascular;
J.P. Peltier, Managing Director of Healthcare Investment Banking at Piper Jaffray; and
Anthony Sine, VP of Business Development, Surgical at Bausch + Lomb.